Introduction
Drug reactions are unwanted reactions of the body following the administration of drugs that are uncharacteristic of the expected pharmacodynamic effects. 1 These include cutaneous adverse drug reactions (CADR), which range from mild pruritus and transient erythema to severe life-threatening conditions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), with significant morbidity and mortality. Sadly, drug reactions are often underreported, and CADR are often misdiagnosed as viral exanthems or attributed to collagen vascular diseases. This in turn may be due to insufficient awareness by healthcare providers, given the emergence of newer classes of drugs with yet unclassified adverse effects as well as evolving prescription profiles. 2, 3 Hence, it is hoped that this clinical audit and review of literature will create the much needed awareness of the epidemiology of CADR, and subsequently influence future, more judicious prescribing practices of healthcare providers.
Methods
A retrospective review of all patients referred to the Department of Dermatology of Hospital Tengku Ampuan Afzan (HTAA), Kuantan, Pahang, Malaysia, with CADR from 2013 to 2016 was carried out to determine the epidemiology of CADR in the local population.
Results
A total of 62 CADR involving 59 patients were seen among 7,353 new patients, yielding an incidence rate of 0.80% (yearly CADR rate range: 0.16 -1.89%). The highest CADR rate was seen among indigenous peoples (Table 1) . Allopurinol was the most common culprit drug causing SJS (7/15) and TEN (2/6). Cotrimoxazole and Cloxacillin were the two most common antimicrobials implicated in CADR, while the most common analgesic was Celecoxib. One-third of our patients took only a single drug, while the average number of drugs taken by a patient was three.
Discussion
Where do we stand against other Asian centers? Table 2 below compares our findings with clinicoepidemiological studies on CADR in Malaysia and various Asian countries. Severe CADR, namely SJS and TEN, were among the most common CADRs observed in the Malaysian hospitals listed above, including ours. This could be due to a referral bias, being dermatology referral centers accepting serious CADRs. This could also explain the lower CADR rate in our cohort compared to 1.38% and 1.5% of dermatology referrals in Denmark 4 and Tunisi 5 , respectively. We now know that there are specific genetic markers for carbamazepineand phenytoin-induced CADRs, namely the HLA-B*15:02 allele predicting the risk of carbamazepine 6-9 as well as phenytoin [10] [11] [12] [13] induced SJS/TEN in South-East Asian populations, HLA-A*31:01 allele for carbamazepine-induced hypersensitivity reactions in European populations 14 , and HLA-B*15:13 for phenytoin-induced SJS/TEN among Malays in Malaysia 10 , and that these allelic markers occur with varying frequency in different ethnic populations. Likewise, HLA-B*13:01 has been reported to be a predictor for dapsone-induced, drug-hypersensitivity syndromes among patients with leprosy. 15 HLA-B*13:01 has also been found among the three main indigenous groups in Peninsular Malaysia, namely the Temuan, Jehai, and Kensiu, with the Kensiu peoples having the highest allele frequency. 16 Whether this holds true for the indigenous peoples of the state of Pahang, resulting in higher CADR rates among them, requires further pharmacogenomic studies. Antimicrobials being the predominant culprit group in almost all of the studies above not only reflects the high infectious diseases burden in tropical and subtropical Asia, but also serves to remind us of more judicious prescriptions of these agents in the future.
Conclusion
SJS was the most common CADR encountered in our center, while the most common culprit drug was allopurinol. Antimicrobials as a group caused the most CADR, and indigenous peoples have a high rate of developing CADR. 
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